• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOCLEAN, INC. SOCLEAN; DREAMSTATIONS CPAP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOCLEAN, INC. SOCLEAN; DREAMSTATIONS CPAP Back to Search Results
Device Problem Nonstandard Device (1420)
Patient Problems Inflammation (1932); Unspecified Respiratory Problem (4464)
Event Date 07/24/2019
Event Type  Injury  
Event Description
On (b)(6) 2020 i became medically disabled from my job.I have a systemic inflammatory condition which affects my nerves, muscles, cartilage and joints, and i have had several surgical procedures with more to come.I also have chronic respiratory issues.After the dreamstation recall, i stopped using the dreamstation and soclean combo, and my condition is regressing without the cpap therapy i had used regularly for a decade.I am unable to get a replacement or repair by philips and soclean won't even give me my money back: the company denies they have any involvement.This isn't right.The company skirted the premarket approval requirement and now has a self admitted monopoly.Used device until i learned of recall and that soclean had not been approved for this use, and had deleterious effects.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOCLEAN
Type of Device
DREAMSTATIONS CPAP
Manufacturer (Section D)
SOCLEAN, INC.
MDR Report Key13060468
MDR Text Key282772619
Report NumberMW5106217
Device Sequence Number1
Product Code LRJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/19/2021
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received12/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ADVAIR ; BOTOX ; CLARITIN ; CLONAZEPAM; CONTRAVE ; CRESTOR ; FLOMAX ; FOLIC ACID ; GABAPENTIN ; MELOXICAM; METHOTREXATE ; MODAFINIL ; NIGHT GUARD; PEPCID ; SINGULAIR ; STEROID NOSE DROPS; TALTZ ; TRAVEL CPAP ; ZYRTEC
Patient Outcome(s) Disability; Hospitalization; Life Threatening; Required Intervention;
Patient Age64 YR
Patient SexMale
Patient Weight106 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-